DMA4-H228
Recommended because it shares a closely related research category or delivery context. Formulation and performance are product- and study-specific.
View product →
Ionizable lipid for LNP and nucleic-acid delivery research.
Compound 22, as detailed in United States Patent US 2026/0014089 A1, is a bifunctional ionizable lipid engineered for precision drug delivery. Its structure integrates a monosaccharide targeting headgroup, designed to bind specifically to DC-SIGN receptors on dendritic cells, via a sophisticated linker connected to a biodegradable lipid anchor. This design enables it to serve as a key component of lipid nanoparticles (LNPs), forming a targeted delivery system. By leveraging the specific carbohydrate-receptor interaction, these LNPs are preferentially internalized by dendritic cells, critical for initiating adaptive immune responses. In vivo studies from the patent, such as the biodistribution data shown in Figure 5, confirm effective accumulation in lymphoid tissues like the spleen and lymph nodes. Consequently, this targeted delivery enhances the potency of encapsulated payloads (e.g., mRNA vaccines) by ensuring professional antigen presentation, eliciting a stronger and more specific immune response—evidenced by higher neutralizing antibody titers—making it a powerful tool for next-generation vaccines and therapeutics.
| CAS No. | Not available |
| Chemical Name | Lipid 22 |
| Synonyms | Lipid-22,Lipid22 |
| SMILES | C=CC.CCC.CCCCCCCCCCCCCCCCCC(=O)OCC(COP(=O)([O-])OCCNC(=O)CCC(=O)NCC/C=C/C=C(\C)O[C@H]1OC(CO)[C@@H](O)[C@H](O)C1O)OC(=O)CCCCCCCCCCCCCCC |
| Formula | C62H116O16N2P- |
| M.Wt | 1,176.58 |
| Purity | >98% |
| Storage | Pure form: −20 °C, 1 year; In solvent: −80 °C, 6 months; −20 °C, 1 month. Sealed and protected from light. |
| Shipping condition | Ships from Shanghai. Pure lipid is stable during ice-pack transport. |
| Publication | Not available |
The product molecular weight is prefilled when available and remains editable. Confirm solvent compatibility and solubility before preparation.
Solvent volumes update from the molecular weight above.
| Mass | 1 mM | 5 mM | 10 mM |
|---|---|---|---|
| 10 mg | 8.4992 mL | 1.6998 mL | 849.92 μL |
| 25 mg | 21.2480 mL | 4.2496 mL | 2.1248 mL |
| 50 mg | 42.4960 mL | 8.4992 mL | 4.2496 mL |
| 100 mg | 84.9921 mL | 16.9984 mL | 8.4992 mL |
| 250 mg | 212.4802 mL | 42.4960 mL | 21.2480 mL |
Contact our team with the catalog number and requested quantity.